Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
The robotic surgery program has continually pushed the boundaries of medical technology
Becomes the first rehab & recovery center in east India to earn NABH accreditation
The partnership marks a significant milestone in integrating digital health education into medical curricula
Subscribe To Our Newsletter & Stay Updated
